Minerva Neurosciences, Inc. (NERV) CEO Remy Luthringer on Q1 2021 Results - Earnings Call Transcript

Minerva Neurosciences, Inc. (NASDAQ:NERV) Q1 2021 Earnings Conference Call May 12, 2021 8:30 AM ET

Company Participants

William Boni - Vice President, Investor Relations & Corporate Communications
Remy Luthringer - Executive Chairman & Chief Executive Officer
Geoff Race - Executive Vice President, Chief Financial Officer & Chief Business Officer

Conference Call Participants

Jason Butler - JMP Securities
Tom Shrader - BTIG
Jay Olson - Oppenheimer
Douglas Tsao - H.C. Wainwright
Myles Minter - William Blair

Operator

Good day, and thank you for standing by. Welcome to the Minerva Neurosciences First Quarter 2021 Conference Call. At this time all participants are in listen only mode. After the speakers presentation there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference may be recorded. [Operator Instructions]

I'd now like to hand the conference over to your host today, Mr. William Boni, Vice President of Investor Relations. Please go ahead.

William Boni

Good morning, everyone. A press release with the company's first quarter 2021 financial results and business highlights became available at 7:30 AM Eastern time today and can be found on the Investors section of our website. Our quarterly report on Form 10-Q was also filed electronically with the SEC this morning and can be found on the SEC's website at www.sec.gov. Joining me on the call today from Minerva are Dr. Remy Luthringer, Executive Chairman and Chief Executive Officer; and Mr. Geoff Race, Executive Vice President, Chief Financial Officer, and Chief Business Officer. Following our prepared remarks, we will open the call for Q&A.

Before we begin, I would like to remind you that today's discussion will include statements about the company's future expectations, plans and prospects that constitute forward-looking statements for purposes of the Safe Harbor provisions under the Private Securities Litigation Reform Act of 1995. We caution that these